Compare the performance and holdings of T Rowe Price Health Sciences Fund, Inc with its Shariah-compliant counterpart
This fund already contains 100% Shariah-compliant stocks.
Fund Name | T Rowe Price Health Sciences Fund, Inc | Fund Type | Mutual Fund |
---|---|---|---|
Inception Date | December 29, 1995 | Investment Segment | Health/Biotech |
Expense Ratio | 0.76% | Total NAV | $15,752,000,000.00 |
PRHSX was founded on 1995-12-29. The Fund's investment strategy focuses on Health/Biotech with 0.76% total expense ratio. The minimum amount to invest in T Rowe Price Health Sciences Fund, Inc is $2,500 on a standard taxable account. T Rowe Price Health Sciences Fund, Inc seeks long-term capital growth by primarily investing in common stocks of companies engaged in the research, development, production, or distribution of health-related products and services.
Retrieved Mar 31, 2025
Icon | Stock | Percent |
---|---|---|
SYRE Non compliant | Spyre Therapeutics | 0.0% |
AGIO Non compliant | Agios Pharm | 0.3% |
AKRO Non compliant | Akero Therapeutics | 0.4% |
ALEC Non compliant | Alector | 0.0% |
ALLO Non compliant | Allogene Therapeutic... | 0.0% |
Includes just the 0 compliant holdings
Icon | Stock | Percent |
---|
Amal Invest offers exclusive access to Shariah-compliant versions of PRHSX and over 100,000 other funds.